Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Group Florence Nightingale
Information provided by (Responsible Party):
Ahmet Selcuk Can, Istanbul Science University
ClinicalTrials.gov Identifier:
NCT00571090
First received: December 10, 2007
Last updated: February 7, 2013
Last verified: February 2013

December 10, 2007
February 7, 2013
June 2003
July 2012   (final data collection date for primary outcome measure)
Thyroid cancer [ Time Frame: one year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00571090 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules
Evaluation of Thyroid Fine Needle Aspiration Biopsies: Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules

The aim of this study is to identify which ultrasonographic feature or a combination of features is the best predictor of thyroid cancer in thyroid nodules.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Probability Sample

Endocrinology Clinic

Thyroid Nodule
Procedure: Thyroid ultrasonography
Ultrasound-guided thyroid fine-needle aspiration biopsy
Thyroid nodule
Subjects who present with thyroid nodules will be enrolled into the study. Euthyroid and hypothyroid subjects with a solitary thyroid nodule or multinodular goiter will be enrolled. For subjects with a suppressed TSH, a thyroid scan will be performed. Subjects with a hypoactive nodule in the thyroid scan and a low TSH will be enrolled.
Intervention: Procedure: Thyroid ultrasonography
Can AS. Cost-effectiveness comparison between palpation- and ultrasound-guided thyroid fine-needle aspiration biopsies. BMC Endocr Disord. 2009 May 16;9:14.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
1000
July 2013
July 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects with thyroid nodules over 10 mm in the longest diameter
  • Euthyroid or hypothyroid subjects with a solitary thyroid nodule or multinodular goiter
  • Subjects with a hypoactive nodule in the thyroid scan and a low TSH

Exclusion Criteria:

  • Subjects with four or more thyroid nodules that are over 10 mm
  • Subjects with low TSH and hyperactive nodule on thyroid scan
Both
15 Years to 89 Years
No
Contact information is only displayed when the study is recruiting subjects
Turkey
 
NCT00571090
B.30.2.IBU.0.01.00.00/511, 511
No
Ahmet Selcuk Can, Istanbul Science University
Istanbul Science University
Group Florence Nightingale
Principal Investigator: Ahmet Selcuk Can, MD Istanbul Science University and Group Florence Nightingale
Istanbul Science University
February 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP